Benzinga · Oct 5, 2026
UBS Maintains Neutral on FMC, Lowers Price Target to $10
UBS analyst Joshua Spector maintains FMC (NYSE:FMC) with a Neutral and lowers the price target from $12 to $10.
NASDAQ · FMC
Basic Materials · Agricultural Inputs
$9.03
Up+$0.06 (+0.66%)
Updated Oct 7, 2026, 11:04 PM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · FMC
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
FMC closed at $9.03 after 21 trading sessions, down 29.51% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $9.05 | $9.30 | $8.96 | $9.03 | 4.51M |
| Oct 5, 2026 | $8.60 | $9.17 | $8.42 | $9.00 | 6.29M |
| Oct 2, 2026 | $8.60 | $8.975 | $8.33 | $8.44 | 7.08M |
| Oct 1, 2026 | $8.92 | $8.9672 | $8.465 | $8.56 | 8.55M |
| Sep 30, 2026 | $9.09 | $9.29 | $8.845 | $8.92 | 5.77M |
| Sep 29, 2026 | $9.22 | $9.395 | $9.07 | $9.09 | 3.15M |
| Sep 28, 2026 | $9.49 | $9.505 | $9.14 | $9.21 | 4.02M |
| Sep 25, 2026 | $9.61 | $9.76 | $9.455 | $9.58 | 3.89M |
| Sep 24, 2026 | $9.90 | $10.11 | $9.54 | $9.59 | 5.32M |
| Sep 23, 2026 | $10.415 | $10.49 | $9.88 | $9.90 | 3.02M |
| Sep 22, 2026 | $10.48 | $10.76 | $10.37 | $10.57 | 3.12M |
| Sep 21, 2026 | $10.24 | $10.355 | $9.95 | $10.28 | 3.72M |
| Sep 18, 2026 | $10.08 | $10.26 | $9.71 | $10.09 | 9.08M |
| Sep 17, 2026 | $10.84 | $10.8725 | $10.145 | $10.20 | 4.48M |
| Sep 16, 2026 | $11.13 | $11.23 | $10.61 | $10.80 | 3.8M |
| Sep 15, 2026 | $10.95 | $11.58 | $10.77 | $11.25 | 3.03M |
| Sep 14, 2026 | $11.22 | $11.515 | $10.98 | $10.98 | 2.95M |
| Sep 11, 2026 | $12.08 | $12.08 | $11.28 | $11.40 | 3M |
| Sep 10, 2026 | $12.07 | $12.45 | $11.89 | $12.08 | 2.1M |
| Sep 9, 2026 | $12.75 | $12.938 | $12.24 | $12.29 | 2.21M |
| Sep 8, 2026 | $13.11 | $13.2299 | $12.57 | $12.81 | 2.33M |
The latest Smart Investors Daily articles mentioning FMC.
Company
Market Activity
Research & News
FMC research
Company profile and research snapshot.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 5, 2026 | UBS | Neutral | — |
| Sep 11, 2026 | Keybanc | Overweight | — |
| Aug 3, 2026 | RBC Capital | Sector Perform | — |
| Jul 31, 2026 | JP Morgan | Neutral | — |
| Jul 31, 2026 | Morgan Stanley | Equal-Weight | — |
No generated briefing is available yet.
Benzinga · Oct 5, 2026
UBS analyst Joshua Spector maintains FMC (NYSE:FMC) with a Neutral and lowers the price target from $12 to $10.
Fintel · Oct 2, 2026
Yahoo · Sep 28, 2026
FMC Corporation Submits Regulatory Dossier for Rimisoxafen, the Industry's First Dual Mode of Action Herbicide, in Brazil
Benzinga · Sep 28, 2026
Second global filing advances rimisoxafen as a novel weed control solution for Brazil's more than 70 million hectares of corn and soybeansFMC Corporation (NYSE:FMC), a leading global agricultural sciences company,
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning FMC.